Skip to main content
Article thumbnail
Location of Repository

A strategy to obtain axenic cultures of Arthrospira spp. cyanobacteria

By Lucia Sena, Diego Rojas, Edie Montiel, Héctor González, Josnell Moret and Leopoldo Naranjo


A strategy to obtain axenic cultures of the cyanobacterium Arthrospira sp. (‘platensis’) Lefevre 1963/M-132-1 strain, consisting of a series of physical and chemical procedures, and the application of an optimized pool of antibiotics, is described in this paper. This strategy, which is an inexpensive and fast way to obtain axenic cultures, can be applied to Arthrospira spp. from culture collections or samples from their natural habitats to eliminate a wide spectrum of contaminants. A high alkaline treatment (pH 12, using KOH) of 72 h is a determinant initial procedure applied to eliminate protozoa and Microcystis sp. Bacteria were eliminated by an optimal antibiotic pool treatment, and Chroococcus sp. residuals were discarded by serial dilution. Optimal concentrations of the antibiotics composing the pool were obtained by a 24 factorial central composite rotatable design (CCRD) and Response Surface Methodology (RSM), resulting in: ampicillin 61.6 μg/ml, penicillin 85.8 μg/ml, cefoxitin 76.9 μg/ml, and meropenem 38.9 μg/ml. The results also indicate that cefoxitin was the most effective antibiotic of this pool. After obtaining the axenic culture, identification of Lefevre 1963/M-132-1 strain was performed using amplification and sequencing of the ITS region (including part of 16S rRNA, tRNA Ile, ITS, tRNA Ala and part of 23S rRNA region) and fatty acid composition data. Data base comparison revealed that Lefevre strain is closely related to A. platensis species (99% identity), while fatty acid composition data suggested A. maxima. These seemingly contradictory results are discussed

Topics: Original Paper
Publisher: Springer Netherlands
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1985). 30:87–92 Hindak F
  2. (1968). A new method for obtaining bacteria-free cultures of blue-green algae.
  3. (1977). Assessment of growth yield of a blue-green alga: Spirulina platensis, in axenic and continuous culture.
  4. (2002). Experimental substantiation of the possibility of developing selenium and iodine containing pharmaceuticals based on blu-green algae Spirulina platensis. J Pharm Biomed Anal 30:87–97 Mu ¨hling
  5. (2005). In: Vonshak A (eds) Spirulina platensis (Arthrospira): physiology, cell-biology and biotechnology.
  6. (1996). Promoting activity of microcystin extracted from warerblooms in SHE cell transformation assay.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.